Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 16,392 shares at $54.83 ($906K) on 2025-11-05, disclosed to the SEC on 2025-11-07.
Scheduled sale ($906k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.62 | 2,300 | $123K | 13.6% |
| 2 | $54.83 | 2,200 | $121K | 13.3% |
| 3 | $55.58 | 5,607 | $312K | 34.4% |
| 4 | $55.58 | 5,607 | $312K | 34.4% |
| 5 | $56.51 | 678 | $38K | 4.2% |
| Total | $55.24 avg | 16,392 |
| $906K |
| 100% |
| Filing → |
| ORKA | SELL | 2026-06-12 | $2.5M | — | Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |